Table 2.
Strain | N | Frequency of genotype, % | |||||
SS I1042, ATT/ATT | RS I/M1042, ATT/ATG | RR M1042, ATG/ATG | RR L1042, TTG | RR M/L1042, ATG/TTG | RR M/F1042, ATG/TTT | ||
BCS-S | 30 | 100 | 0 | 0 | |||
Sudlon | 30 | 97 | 0 | 3 | |||
Sudlon-Tfm | 40 | 0 | 0 | 100 | |||
Japan | 30 | 50 | 43 | 7 | |||
Japan* | 6 | 0 | 0 | 100 | |||
Px-China | 59 | 27 | 20 | 25 | 3 | 2 | 22 |
Px-India | 23 | 52 | 30 | 17 | |||
Reciprocal crosses | |||||||
F1-A (BCS-S × Sudlon-Tfm) | 40 | 0 | 100 | 0 | |||
F1-B (Sudlon × Sudlon-Tfm) | 63 | 0 | 89 | 11 |
Survivors of BPU treatment (>100 ppm).